Compounds target viral sugars for broad protection

Scientists have developed compounds targeting viral sugars, showing promise for a universal antiviral drug. Four compounds successfully blocked infections from seven different viruses, including Ebola and coronaviruses, by binding to surface sugars common across many virus families. This breakthrough could provide a crucial first line of defense against emerging pandemic threats, offering a broad-spectrum alternative to specialized antivirals.